Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CUE US Equity

Cue Biopharma, Inc.Health Care · Pharmaceutical Preparations · CIK 1645460 · FY ends Dec 31
$26.28
+0.58 (+2.26%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by DRIEHAUS CAPITAL MANAGEMENT LLCsec.gov ↗
2026-08-038-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-108-K 8.01Other eventssec.gov ↗
2026-07-108-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-108-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-07-108-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-10

Every row is a filed document, checked against its EDGAR index.